In her fight with cancer, Newmarket resident Camille Leahy had to battle against more than just the disease.
Diagnosed with acute lymphoblastic leukemia in January 2020, Leahy described the struggles of going through various treatments. After having a cancer resurgence in 2021 and being unable to bear the idea of another long chemotherapy treatment separated from her family due to pandemic public health measures, she sought another option.
She found it in a clinical trial in Ottawa for a treatment called chimeric antigen receptor-modified T cells (CAR-T). After three attempts, she got into the trial — and it has given her a new lease on life, she said. She had a complete response, with no more cancer detected in her blood.
Read the full Newmarket Today article:
https://www.newmarkettoday.ca/local-news/newmarket-cancer-patient-credits-trial-treatment-for-saving-life-5939901
